Dr. Thomas J. Stegmann’s discovery of ways to stimulate growth of new blood vessels in the human heart opens up an exciting new area of biotechnology and medical treatment for cardiovascular disease. His research and subsequent trials have been articulated in an acclaimed volume, New Vessels for the Heart: Angiogenesis as New Treatment for Coronary Heart Disease: The Story of its Discovery and Development, published in 2005.

Thomas J. Stegmann, M.D., Ph.D.

Now Available from CardioVascular BioTherapeutics:

New Vessels for the Heart

by Thomas J. Stegmann, M.D., Ph.D.

This publication explains his discovery, the first scientific steps, and the 13-year journey that led to the current status of CVBT’s human clinical trials in the United States. Dr. Stegmann describes the fascinating extension of that new treatment principle to represent an overwhelming potential for the therapy of a variety of diseases, such as stroke, wound-healing disturbances, chronic back pain, neurological disorders and others.

Now, you can read the story of the development and discovery of CVBT-141A for yourself in Dr. Stegmann’s book.

Order now and have a complimentary copy of Dr. Stegmann's book sent to you.

Holding a Woman’s Heart in My Hands

by Thomas J. Stegmann, M.D., Ph.D.

This informative booklet addresses the unique medical issues women’s heart disease presents in both diagnosis and treatment, and how angiogenesis—the growth of new blood vessels in the heart—could be a new medical therapy to treat this disease, which kills more than 480,000 women a year, according to the American Heart Association.

To request a complimentary copy of this booklet, please send an email with your name & mailing address to womensheartdisease@cvbt.com.

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.